Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Drug metabolism >  VITAMIN K1

VITAMIN K1

Basic information Safety Supplier Related

VITAMIN K1 Basic information

Product Name:
VITAMIN K1
Synonyms:
  • vitamine K
  • VITAMIN K
  • Synkavite
  • 2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
  • VITAMIN K1 USP23
  • Kanavit
  • Vitamin K substances
  • C01628
CAS:
12001-79-5
MF:
C31H46O2
MW:
450.7
EINECS:
234-408-7
Product Categories:
  • Miscellaneous Natural Products
  • API
Mol File:
12001-79-5.mol
More
Less

VITAMIN K1 Chemical Properties

Melting point:
−20 °C(lit.)
Density 
0.984 g/mL at 25 °C(lit.)
refractive index 
n20/D 1.527(lit.)
Flash point:
>230 °F
storage temp. 
2-8°C
solubility 
Soluble in DMSO
form 
viscous liquid
color 
Light yellow to yellow
LogP
10.305 (est)
CAS DataBase Reference
12001-79-5
IARC
3 (Vol. 76) 2000
EPA Substance Registry System
Vitamin K (12001-79-5)
More
Less

Safety Information

WGK Germany 
2
RTECS 
QJ5800000
1-8-10
Toxicity
mouse,LD50,subcutaneous,700mg/kg (700mg/kg),Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 25, 1958.

MSDS

More
Less

VITAMIN K1 Usage And Synthesis

Definition

ChEBI: 2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione is a member of 1,4-naphthoquinones.

Biological Functions

Both vitamins K3 and K4 may produce hyperbilirubinemia and kernicterus in neonates as well as hemolysis in neonates and glucose-6-phosphate–deficient patients. In fact, the only advantage of vitamins K3 and K4 over vitamin K1 is that whereas absorption of vitamin K1 requires the presence of bile, absorption of vitamins K3 and K4 does not, because they are absorbed via a passive process directly from the intestine. This may be a slight advantage for patients with cholestasis or severe pancreatic dysfunction. Only vitamin K1, however, is appropriate therapy for bleeding associated with warfarin and superwarfarin anticoagulation. Vitamin K2 is not used therapeutically.

Mechanism of action

Vitamin K antagonists, such as warfarin, produce their effect on blood coagulation by interfering with the cyclic interconversion of vitamin K and vitamin K 2,3-epoxide. Vitamin K is an essential cofactor necessary for the posttranslational carboxylation of the glutamic acid residues on the N-terminal portions of the specific clotting factors (II, VII, IX, and X) and anticoagulant proteins, such as protein C. This γ-glutamyl carboxylation results in a new amino acid, γ-carboxyglutamate, which through chelation of calcium ions causes the proteins to undergo a conformational change. This change in tertiary structure allows the four vitamin K–dependent clotting factors to become activated and bind to the negatively charged phospholipid membranes during clotting cascade activation.

Pharmacokinetics

The half-life of vitamin K1 is quite short—only 1.7 hours via the intravenous route and 3–5 hours via the oral route. When given orally, vitamin K1 is absorbed directly from the proximal small intestine in an energy-dependent and saturable process that requires the presence of bile salts. These kinetic features argue for administration in divided doses rather than larger, single daily doses. The typical starting point for adults with drug-induced hypoprothrombinemia is 2.5 to 10 mg of vitamin K1 orally, repeating in 12 to 48 hours if needed. In cases of ingestion of long-acting superwarfarin rodenticides (e.g., brodifacoum), therapy may be 125 mg/day for weeks or months. Practically speaking, because vitamin K1 is dispensed as 5-mg tablets, superwarfarin-poisoned patients may require 10 to 30 tablets every 6 hours.

Clinical Use

Vitamin K1 (phytonadione, Mephyton) is the form of vitamin K most often used therapeutically. Vitamin K1 is safe for use in infants, pregnant women, and patients with glucose-6-phosphate deficiency.

Safety Profile

Moderately toxic by subcutaneous route. An experimental teratogen. When heated to decomposition it emits acrid smoke and irritating fumes.

VITAMIN K1Supplier

Hangzhou Yuhao Chemical Technology Co., Ltd
Tel
0571-82693216
Email
info@yuhaochemical.com
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939 15221275939
Email
shenlinxing@macklin.cn
Shanghai Synchem Pharma Co., ltd
Tel
21-619849051-1 18521059765
Email
synchempharma@aliyun.com
Chengdu Push Bio-Technology Co., Ltd.
Tel
028-85370565-229 18080489829
Email
3004654993@qq.com